The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Coagulation is the process, by which blood changes from a liquid to a gel, forming a blood clot. In general terms, coagulation is a process in which the blood forms clots to block and then heal a lesion/wound/cut and stop the bleeding.
The global Blood Coagulants market was valued at US$ 391.9 million in 2023 and is anticipated to reach US$ 628.6 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry.
The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Coagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Coagulants.
Report Scope
The Blood Coagulants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Coagulants market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Coagulants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
Market Segmentation
By Company
- Pfizer
- Bayer
- Novo Nordisk
- Takeda
- SOBI
- Octapharma
- CSL
Segment by Type
- Recombinant Coagulation Factor
- Plasma Coagulation Factor
Segment by Sale Channel
- Hospital
- Pharmacy
- Other
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Blood Coagulants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Blood Coagulants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Blood Coagulants Market Overview
1.1 Product Overview and Scope of Blood Coagulants
1.2 Blood Coagulants Segment by Type
1.2.1 Global Blood Coagulants Market Value Comparison by Type (2024-2030)
1.2.2 Recombinant Coagulation Factor
1.2.3 Plasma Coagulation Factor
1.3 Blood Coagulants Segment by Sale Channel
1.3.1 Global Blood Coagulants Market Value by Sale Channel: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Blood Coagulants Market Size Estimates and Forecasts
1.4.1 Global Blood Coagulants Revenue 2019-2030
1.4.2 Global Blood Coagulants Sales 2019-2030
1.4.3 Global Blood Coagulants Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Blood Coagulants Market Competition by Manufacturers
2.1 Global Blood Coagulants Sales Market Share by Manufacturers (2019-2024)
2.2 Global Blood Coagulants Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Blood Coagulants Average Price by Manufacturers (2019-2024)
2.4 Global Blood Coagulants Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Blood Coagulants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Blood Coagulants, Product Type & Application
2.7 Blood Coagulants Market Competitive Situation and Trends
2.7.1 Blood Coagulants Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Blood Coagulants Players Market Share by Revenue
2.7.3 Global Blood Coagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Blood Coagulants Retrospective Market Scenario by Region
3.1 Global Blood Coagulants Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Blood Coagulants Global Blood Coagulants Sales by Region: 2019-2030
3.2.1 Global Blood Coagulants Sales by Region: 2019-2024
3.2.2 Global Blood Coagulants Sales by Region: 2025-2030
3.3 Global Blood Coagulants Global Blood Coagulants Revenue by Region: 2019-2030
3.3.1 Global Blood Coagulants Revenue by Region: 2019-2024
3.3.2 Global Blood Coagulants Revenue by Region: 2025-2030
3.4 North America Blood Coagulants Market Facts & Figures by Country
3.4.1 North America Blood Coagulants Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Blood Coagulants Sales by Country (2019-2030)
3.4.3 North America Blood Coagulants Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Blood Coagulants Market Facts & Figures by Country
3.5.1 Europe Blood Coagulants Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Blood Coagulants Sales by Country (2019-2030)
3.5.3 Europe Blood Coagulants Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Coagulants Market Facts & Figures by Country
3.6.1 Asia Pacific Blood Coagulants Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Blood Coagulants Sales by Country (2019-2030)
3.6.3 Asia Pacific Blood Coagulants Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Blood Coagulants Market Facts & Figures by Country
3.7.1 Latin America Blood Coagulants Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Blood Coagulants Sales by Country (2019-2030)
3.7.3 Latin America Blood Coagulants Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood Coagulants Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Coagulants Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Blood Coagulants Sales by Country (2019-2030)
3.8.3 Middle East and Africa Blood Coagulants Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Blood Coagulants Sales by Type (2019-2030)
4.1.1 Global Blood Coagulants Sales by Type (2019-2024)
4.1.2 Global Blood Coagulants Sales by Type (2025-2030)
4.1.3 Global Blood Coagulants Sales Market Share by Type (2019-2030)
4.2 Global Blood Coagulants Revenue by Type (2019-2030)
4.2.1 Global Blood Coagulants Revenue by Type (2019-2024)
4.2.2 Global Blood Coagulants Revenue by Type (2025-2030)
4.2.3 Global Blood Coagulants Revenue Market Share by Type (2019-2030)
4.3 Global Blood Coagulants Price by Type (2019-2030)
5 Segment by Sale Channel
5.1 Global Blood Coagulants Sales by Sale Channel (2019-2030)
5.1.1 Global Blood Coagulants Sales by Sale Channel (2019-2024)
5.1.2 Global Blood Coagulants Sales by Sale Channel (2025-2030)
5.1.3 Global Blood Coagulants Sales Market Share by Sale Channel (2019-2030)
5.2 Global Blood Coagulants Revenue by Sale Channel (2019-2030)
5.2.1 Global Blood Coagulants Revenue by Sale Channel (2019-2024)
5.2.2 Global Blood Coagulants Revenue by Sale Channel (2025-2030)
5.2.3 Global Blood Coagulants Revenue Market Share by Sale Channel (2019-2030)
5.3 Global Blood Coagulants Price by Sale Channel (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Blood Coagulants Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Blood Coagulants Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Blood Coagulants Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Blood Coagulants Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Novo Nordisk
6.3.1 Novo Nordisk Corporation Information
6.3.2 Novo Nordisk Description and Business Overview
6.3.3 Novo Nordisk Blood Coagulants Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novo Nordisk Blood Coagulants Product Portfolio
6.3.5 Novo Nordisk Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Corporation Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Blood Coagulants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Takeda Blood Coagulants Product Portfolio
6.4.5 Takeda Recent Developments/Updates
6.5 SOBI
6.5.1 SOBI Corporation Information
6.5.2 SOBI Description and Business Overview
6.5.3 SOBI Blood Coagulants Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SOBI Blood Coagulants Product Portfolio
6.5.5 SOBI Recent Developments/Updates
6.6 Octapharma
6.6.1 Octapharma Corporation Information
6.6.2 Octapharma Description and Business Overview
6.6.3 Octapharma Blood Coagulants Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Octapharma Blood Coagulants Product Portfolio
6.6.5 Octapharma Recent Developments/Updates
6.7 CSL
6.6.1 CSL Corporation Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Blood Coagulants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSL Blood Coagulants Product Portfolio
6.7.5 CSL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Coagulants Industry Chain Analysis
7.2 Blood Coagulants Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Coagulants Production Mode & Process
7.4 Blood Coagulants Sales and Marketing
7.4.1 Blood Coagulants Sales Channels
7.4.2 Blood Coagulants Distributors
7.5 Blood Coagulants Customers
8 Blood Coagulants Market Dynamics
8.1 Blood Coagulants Industry Trends
8.2 Blood Coagulants Market Drivers
8.3 Blood Coagulants Market Challenges
8.4 Blood Coagulants Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
